tiprankstipranks
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H (HK:1858)
:1858
Hong Kong Market
1858
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H
RESEARCH TOOLSreports

Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H (1858) Ratios

1 Followers

Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H Ratios

HK:1858's free cash flow for Q4 2025 was ¥0.61. For the 2025 fiscal year, HK:1858's free cash flow was decreased by ¥ and operating cash flow was ¥0.31. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 5.20 5.20 5.20 4.44 4.66
Quick Ratio
 5.20 4.28 4.19 3.80 4.23
Cash Ratio
 2.44 2.44 2.08 1.87 1.61
Solvency Ratio
 0.52 0.52 0.25 0.41 0.49
Operating Cash Flow Ratio
 0.72 0.71 >-0.01 0.76 0.07
Short-Term Operating Cash Flow Coverage
 130.25 128.86 0.00 0.00 0.00
Net Current Asset Value
¥ 2.42B¥ 2.42B¥ 2.20B¥ 2.24B¥ 2.09B
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.23 1.23 1.23 1.27 1.25
Debt Service Coverage Ratio
 95.93 80.35 3.61K 856.65 7.23K
Interest Coverage Ratio
 7.71K 1.29K 2.91K 838.61 7.04K
Debt to Market Cap
 <0.01 <0.01 0.00 0.00 0.00
Interest Debt Per Share
 <0.01 0.01 <0.01 <0.01 <0.01
Net Debt to EBITDA
 -4.16 -4.69 -6.73 -3.71 -2.60
Profitability Margins
Gross Profit Margin
65.54%63.29%64.09%72.48%76.03%
EBIT Margin
28.86%25.64%16.34%25.32%28.04%
EBITDA Margin
32.35%29.67%21.01%28.19%30.54%
Operating Profit Margin
28.91%25.64%16.22%25.32%27.37%
Pretax Profit Margin
28.86%29.04%16.33%25.31%28.04%
Net Profit Margin
26.07%26.23%15.51%22.99%25.61%
Continuous Operations Profit Margin
26.07%29.04%15.47%22.99%25.61%
Net Income Per EBT
90.34%90.34%94.98%90.82%91.34%
EBT Per EBIT
99.82%113.23%100.68%99.98%102.42%
Return on Assets (ROA)
7.43%7.24%3.61%7.61%9.02%
Return on Equity (ROE)
9.26%8.88%4.43%9.66%11.31%
Return on Capital Employed (ROCE)
9.79%8.40%4.48%10.29%11.69%
Return on Invested Capital (ROIC)
8.83%7.58%4.24%9.34%10.67%
Return on Tangible Assets
7.68%7.48%3.74%7.94%9.41%
Earnings Yield
3.46%5.18%4.11%6.69%5.69%
Efficiency Ratios
Receivables Turnover
 4.51 4.36 2.03 2.74 1.57
Payables Turnover
 2.25 2.31 1.27 1.48 1.21
Inventory Turnover
 0.00 0.69 0.53 0.77 1.11
Fixed Asset Turnover
 0.00 2.07 1.72 2.60 2.58
Asset Turnover
 0.29 0.28 0.23 0.33 0.35
Working Capital Turnover Ratio
 0.43 0.43 0.35 0.54 0.57
Cash Conversion Cycle
 -81.30 452.93 586.86 362.73 260.98
Days of Sales Outstanding
 80.94 83.63 179.44 133.41 233.10
Days of Inventory Outstanding
 0.00 527.56 694.81 476.76 329.16
Days of Payables Outstanding
 162.24 158.26 287.39 247.44 301.28
Operating Cycle
 80.94 611.19 874.25 610.17 562.26
Cash Flow Ratios
Operating Cash Flow Per Share
 1.08 1.07 >-0.01 1.33 0.11
Free Cash Flow Per Share
 0.92 0.92 -0.13 1.24 0.04
CapEx Per Share
 0.15 0.15 0.13 0.09 0.06
Free Cash Flow to Operating Cash Flow
 0.86 0.86 26.89 0.94 0.39
Dividend Paid and CapEx Coverage Ratio
 2.62 2.66 >-0.01 3.34 0.55
Capital Expenditure Coverage Ratio
 7.00 7.11 -0.04 15.39 1.65
Operating Cash Flow Coverage Ratio
 109.62 108.44 -2.19 291.92 31.20
Operating Cash Flow to Sales Ratio
 0.40 0.41 >-0.01 0.42 0.03
Free Cash Flow Yield
4.53%6.88%-1.68%11.52%0.30%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 28.91 19.30 24.31 14.95 17.57
Price-to-Sales (P/S) Ratio
 7.50 5.06 3.77 3.44 4.50
Price-to-Book (P/B) Ratio
 2.63 1.71 1.08 1.44 1.99
Price-to-Free Cash Flow (P/FCF) Ratio
 22.08 14.53 -59.48 8.68 335.68
Price-to-Operating Cash Flow Ratio
 19.01 12.49 -1.60K 8.12 131.82
Price-to-Earnings Growth (PEG) Ratio
 4.84 0.18 -0.45 -1.50 -1.26
Price-to-Fair Value
 2.63 1.71 1.08 1.44 1.99
Enterprise Value Multiple
 19.03 12.37 11.22 8.48 12.13
Enterprise Value
 6.43B 3.71B 1.90B 2.89B 4.45B
EV to EBITDA
 19.03 12.37 11.22 8.48 12.13
EV to Sales
 6.16 3.67 2.36 2.39 3.70
EV to Free Cash Flow
 18.12 10.54 -37.18 6.04 276.32
EV to Operating Cash Flow
 15.53 9.06 -999.69 5.65 108.51
Tangible Book Value Per Share
 7.68 7.70 7.11 7.07 6.73
Shareholders’ Equity Per Share
 7.78 7.79 7.45 7.46 7.09
Tax and Other Ratios
Effective Tax Rate
 0.10 0.10 0.05 0.09 0.09
Revenue Per Share
 2.72 2.64 2.13 3.13 3.13
Net Income Per Share
 0.71 0.69 0.33 0.72 0.80
Tax Burden
 0.90 0.90 0.95 0.91 0.91
Interest Burden
 1.00 1.13 1.00 1.00 1.00
Research & Development to Revenue
 0.17 0.00 0.17 0.13 0.14
SG&A to Revenue
 0.35 0.00 0.35 <0.01 <0.01
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 1.52 1.54 -0.02 1.84 0.13
Currency in CNY